Logo image of CGBS

CROWN LNG HOLDINGS LTD (CGBS) Stock Fundamental Analysis

NASDAQ:CGBS - Nasdaq - JE00BPSKDR41 - Common Stock - Currency: USD

0.0371  -0.02 (-39.48%)

After market: 0.0166 -0.02 (-55.26%)

Fundamental Rating

1

CGBS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 208 industry peers in the Oil, Gas & Consumable Fuels industry. CGBS has a bad profitability rating. Also its financial health evaluation is rather negative. CGBS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CGBS had negative earnings in the past year.
CGBS had a negative operating cash flow in the past year.
CGBS Yearly Net Income VS EBIT VS OCF VS FCFCGBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2020 2021 2022 2023 0 -5M -10M -15M -20M -25M

1.2 Ratios

CGBS's Return On Assets of -11.89% is on the low side compared to the rest of the industry. CGBS is outperformed by 85.24% of its industry peers.
Looking at the Return On Equity, with a value of -13.55%, CGBS is doing worse than 75.71% of the companies in the same industry.
Industry RankSector Rank
ROA -11.89%
ROE -13.55%
ROIC N/A
ROA(3y)-32.56%
ROA(5y)N/A
ROE(3y)-74.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGBS Yearly ROA, ROE, ROICCGBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

CGBS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGBS Yearly Profit, Operating, Gross MarginsCGBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2020 2021 2022 2023

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CGBS has about the same amount of shares outstanding.
Compared to 1 year ago, CGBS has an improved debt to assets ratio.
CGBS Yearly Shares OutstandingCGBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2020 2021 2022 2023 10M 20M 30M 40M 50M
CGBS Yearly Total Debt VS Total AssetsCGBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CGBS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, CGBS belongs to the top of the industry, outperforming 81.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CGBS Yearly LT Debt VS Equity VS FCFCGBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

CGBS has a Current Ratio of 0.22. This is a bad value and indicates that CGBS is not financially healthy enough and could expect problems in meeting its short term obligations.
CGBS has a Current ratio of 0.22. This is amonst the worse of the industry: CGBS underperforms 94.76% of its industry peers.
CGBS has a Quick Ratio of 0.22. This is a bad value and indicates that CGBS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.22, CGBS is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
CGBS Yearly Current Assets VS Current LiabilitesCGBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2020 2021 2022 2023 5M 10M 15M

0

3. Growth

3.1 Past

The earnings per share for CGBS have decreased strongly by -1353.89% in the last year.
EPS 1Y (TTM)-1353.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CGBS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGBS Price Earnings VS Forward Price EarningsCGBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBS Per share dataCGBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CGBS!.
Industry RankSector Rank
Dividend Yield N/A

CROWN LNG HOLDINGS LTD

NASDAQ:CGBS (7/16/2025, 8:00:00 PM)

After market: 0.0166 -0.02 (-55.26%)

0.0371

-0.02 (-39.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.06%
Inst Owner ChangeN/A
Ins Owners38.46%
Ins Owner ChangeN/A
Market Cap18.16M
AnalystsN/A
Price TargetN/A
Short Float %2.65%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.42
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.89%
ROE -13.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.56%
ROA(5y)N/A
ROE(3y)-74.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1353.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-926.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-549.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-549.3%
OCF growth 3YN/A
OCF growth 5YN/A